BD Visitec Nucleus Expression Cannulas
Navigation Links
BD Visitec Nucleus Expression Cannulas
| Products | BD Visitec Nucleus Expression Cannulas |
| Company | BD Ophthalmics |
| Item | BD Visitec Nucleus Expression Cannulas |
| Features | |
| Description | |
| Info | BD Ophthalmics Customer Service: (800) 237-2174 Web site: http://www.bd.com/ophthalmology |
Related medicine products :
1. BD Visitec IOL Manipulator (Jaffe-Maltzman)
2. BD Visitec IOL Manipulator (Lester)
3. BD Visitec IOL Manipulator (Sinskey)
4. BD Visitec™ button tip manipulator
5. BD Visitec IOL Manipulator (Fenzl)
6. BD Visitec IOL Manipulator
7. BD Visitec Capsule Polishers
8. BD Visitec Iris Retractors
9. BD Visitec Irrigation and Aspiration Cannulas
10. BD Visitec J Shape Cannulas
11. BD Visitec Cortex Extractors
Breaking Medicine News(10 mins):Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:Lilly Announces the First 300-unit Vial of Insulin 2Health News:Lilly Announces the First 300-unit Vial of Insulin 3Health News:Lilly Announces the First 300-unit Vial of Insulin 4Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 2Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 3Health News:Prostate Hormone Therapy May Up Heart Risks 2Health News:Prostate Hormone Therapy May Up Heart Risks 3Health News:New approach to sickle-cell disease shows promise in mice 2
[0] City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans[0] Lilly Announces the First 300-unit Vial of Insulin[0] Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health[0] Prostate Hormone Therapy May Up Heart Risks[1] New approach to sickle-cell disease shows promise in mice
Other Medicine News:Health News:Dry Eye Syndrome Affects Visual Functions 2Health News:Combination of Depression and Type-2-diabetes Lethal for Heart Patients 2Health News:Health Care Systems for Critically Ill Patients Need Restructuring 2Health News:Want a Healthy Colon? Eat a Rainbow! 2Health News:Spain Launches Movement Against Skinny Fashion Models 2Health News:Spain Launches Movement Against Skinny Fashion Models 3
Dry Eye Syndrome Affects Visual FunctionsCombination of Depression and Type-2-diabetes Lethal for Heart PatientsHealth Care Systems for Critically Ill Patients Need RestructuringWant a Healthy Colon? Eat a Rainbow!Delhi Kids to Be Immunized Against PolioSpain Launches Movement Against Skinny Fashion Models
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5OPAXIO 28TM 29 Combined with Alimta 28R 29 Well Tolerated in Dose Ranging Study of Patients with Advanced Non Small Cell Lung Cancer 4808 1OPAXIO 28TM 29 Combined with Alimta 28R 29 Well Tolerated in Dose Ranging Study of Patients with Advanced Non Small Cell Lung Cancer 4808 2OPAXIO 28TM 29 Combined with Alimta 28R 29 Well Tolerated in Dose Ranging Study of Patients with Advanced Non Small Cell Lung Cancer 4808 3Dysport proves safe effective anti wrinkle treatment UT Southwestern plastic surgeons find 53439 1Dysport proves safe effective anti wrinkle treatment UT Southwestern plastic surgeons find 53439 2Beckman Coulter Completes Acquisition of Olympus Lab Based Diagnostics Business 13318 1Beckman Coulter Completes Acquisition of Olympus Lab Based Diagnostics Business 13318 2
[0] Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease[0] ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program[0] The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |